Gsk Quarterly Results 2025. Gsk (gsk) announced its q4 2023 results, exceeding estimates with a 15% yoy growth in sales and citing 12 major product launches from 2025. Strengthened balance sheet post separation supports investment in growth.
Strong sales growth across biopharma and consumer healthcare. Gsk (gsk) announced its q4 2023 results, exceeding estimates with a 15% yoy growth in sales and citing 12 major product launches from 2025.
British Drug Major Gsk Plc ( Gsk, Gsk.l) Wednesday Reported Sharply Lower Profit In Its Fourth Quarter, Despite Higher Revenues.
The company’s focus areas are therapies for respiratory diseases.
Gsk Last Posted Its Quarterly Earnings Data On May 1St, 2024.
The table below shows the full dividend history for gsk plc.
Gsk Quarterly Results 2025 Images References :
The Previous Gsk Plc (Gsk) Dividend Was 15P And Was Paid Yesterday.
The pharmaceutical company reported $1.09 earnings per share (eps) for the quarter,.
Gsk Last Posted Its Quarterly Earnings Data On May 1St, 2024.